BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 35454069)

  • 1. Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity.
    Aminu B; Fux J; Mallette E; Petersen N; Zhang W
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor Elimination by E3 Ubiquitin Ligase Recruitment (REULR): A Targeted Protein Degradation Toolbox.
    Siepe DH; Picton LK; Garcia KC
    ACS Synth Biol; 2023 Apr; 12(4):1081-1093. PubMed ID: 37011906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System.
    Radhakrishnan S; Hoff O; Muellner MK
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the arsenal of E3 ubiquitin ligases for proximity-induced protein degradation.
    Kannt A; Đikić I
    Cell Chem Biol; 2021 Jul; 28(7):1014-1031. PubMed ID: 33945791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
    Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
    J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation.
    Maniaci C; Hughes SJ; Testa A; Chen W; Lamont DJ; Rocha S; Alessi DR; Romeo R; Ciulli A
    Nat Commun; 2017 Oct; 8(1):830. PubMed ID: 29018234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin proteasome system in immune regulation and therapeutics.
    Bhat SA; Vasi Z; Adhikari R; Gudur A; Ali A; Jiang L; Ferguson R; Liang D; Kuchay S
    Curr Opin Pharmacol; 2022 Dec; 67():102310. PubMed ID: 36288660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.
    Burande CF; Heuzé ML; Lamsoul I; Monsarrat B; Uttenweiler-Joseph S; Lutz PG
    Mol Cell Proteomics; 2009 Jul; 8(7):1719-27. PubMed ID: 19376791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HECT E3 ubiquitin ligase Nedd4-1 ubiquitinates ACK and regulates epidermal growth factor (EGF)-induced degradation of EGF receptor and ACK.
    Lin Q; Wang J; Childress C; Sudol M; Carey DJ; Yang W
    Mol Cell Biol; 2010 Mar; 30(6):1541-54. PubMed ID: 20086093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction.
    Nguyen HC; Wang W; Xiong Y
    Subcell Biochem; 2017; 83():323-347. PubMed ID: 28271482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1.
    Thompson JW; Nagel J; Hoving S; Gerrits B; Bauer A; Thomas JR; Kirschner MW; Schirle M; Luchansky SJ
    J Biol Chem; 2014 Oct; 289(42):28942-55. PubMed ID: 25147182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding PROTACtable genome universe of E3 ligases.
    Liu Y; Yang J; Wang T; Luo M; Chen Y; Chen C; Ronai Z; Zhou Y; Ruppin E; Han L
    Nat Commun; 2023 Oct; 14(1):6509. PubMed ID: 37845222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes.
    Zhang W; Wu KP; Sartori MA; Kamadurai HB; Ordureau A; Jiang C; Mercredi PY; Murchie R; Hu J; Persaud A; Mukherjee M; Li N; Doye A; Walker JR; Sheng Y; Hao Z; Li Y; Brown KR; Lemichez E; Chen J; Tong Y; Harper JW; Moffat J; Rotin D; Schulman BA; Sidhu SS
    Mol Cell; 2016 Apr; 62(1):121-36. PubMed ID: 26949039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligandability of E3 Ligases for Targeted Protein Degradation Applications.
    Belcher BP; Ward CC; Nomura DK
    Biochemistry; 2023 Feb; 62(3):588-600. PubMed ID: 34473924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing pathways in neurodegenerative disorders and cancer.
    Kaushik A; Parashar S; Ambasta RK; Kumar P
    Ageing Res Rev; 2024 Apr; 96():102279. PubMed ID: 38521359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. βarrestin-1 regulates DNA repair by acting as an E3-ubiquitin ligase adaptor for 53BP1.
    Nieto A; Hara MR; Quereda V; Grant W; Saunders V; Xiao K; McDonald PH; Duckett DR
    Cell Death Differ; 2020 Apr; 27(4):1200-1213. PubMed ID: 31506606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation.
    Márquez-Cantudo L; Ramos A; Coderch C; de Pascual-Teresa B
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making sense of ubiquitin ligases that regulate p53.
    Jain AK; Barton MC
    Cancer Biol Ther; 2010 Oct; 10(7):665-72. PubMed ID: 20930521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive database of human E3 ubiquitin ligases: application to aquaporin-2 regulation.
    Medvar B; Raghuram V; Pisitkun T; Sarkar A; Knepper MA
    Physiol Genomics; 2016 Jul; 48(7):502-12. PubMed ID: 27199454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Nedd4-like ubiquitin E3 ligases target angiomotin/p130 to ubiquitin-dependent degradation.
    Wang C; An J; Zhang P; Xu C; Gao K; Wu D; Wang D; Yu H; Liu JO; Yu L
    Biochem J; 2012 Jun; 444(2):279-89. PubMed ID: 22385262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.